Magnus Løberg1,2, Mette Kalager3,4,5, Geir Hoff6,7. 1. Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Postbox 1089, 0318, Blindern, Oslo, Norway. magnus.loberg@medisin.uio.no. 2. Department of Transplantation Medicine and KG Jebsen Colorectal Cancer Research Center, Oslo University Hospital, Oslo, Norway. magnus.loberg@medisin.uio.no. 3. Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Postbox 1089, 0318, Blindern, Oslo, Norway. 4. Department of Transplantation Medicine and KG Jebsen Colorectal Cancer Research Center, Oslo University Hospital, Oslo, Norway. 5. Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA. 6. Telemark Hospital, Skien, Norway. 7. Cancer Registry of Norway, Oslo, Norway.
Authors: Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann Journal: BMJ Date: 2008-04-26
Authors: Øyvind Holme; Magnus Løberg; Mette Kalager; Michael Bretthauer; Miguel A Hernán; Eline Aas; Tor J Eide; Eva Skovlund; Jørn Schneede; Kjell Magne Tveit; Geir Hoff Journal: JAMA Date: 2014-08-13 Impact factor: 56.272